Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ContraBand™ Safety & Feasibility Study for Treatment of Heart Failure

NCT05230745 is registered in ClinicalTrials.gov with Restore Medical Ltd as lead sponsor.

NCT NCT05230745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05230745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ContraBand™ Safety & Feasibility Study for Treatment of Heart Failure
Lead sponsor
Restore Medical Ltd
Phase
Not applicable
Overall status
Recruiting
Start date
September 28, 2021
Completion date
December 31, 2032
Enrollment
55 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, left sided